Crosbie EJ, Kitson SJ, McAlpine JN, Mukhopadhyay A, Powell ME, Singh N. Endometrial cancer. Lancet. 2022;399(10333):1412–28.

Article  PubMed  Google Scholar 

Gu B, Shang X, Yan M, Li X, Wang W, Wang Q, Zhang C. Variations in incidence and mortality rates of endometrial cancer at the global, regional, and national levels, 1990–2019. Gynecol Oncol. 2021;161(2):573–80.

Article  PubMed  Google Scholar 

Nagase S, Katabuchi H, Hiura M, Sakuragi N, Aoki Y, Kigawa J, Saito T, Hachisuga T, Ito K, Uno T, et al. Evidence-based guidelines for treatment of uterine body neoplasm in Japan: Japan Society of Gynecologic Oncology (JSGO) 2009 edition. Int J Clin Oncol. 2010;15(6):531–42.

Article  PubMed  Google Scholar 

Donadieu J, Fenneteau O, Beaupain B, Mahlaoui N, Chantelot CB. Congenital neutropenia: diagnosis, molecular bases and patient management. Orphanet J Rare Dis. 2011;6:26.

Article  PubMed  PubMed Central  Google Scholar 

Kuderer NM, Dale DC, Crawford J, Cosler LE, Lyman GH. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer. 2006;106(10):2258–66.

Article  PubMed  Google Scholar 

Keng MK, Sekeres MA. Febrile neutropenia in hematologic malignancies. Curr Hematol Malig Rep. 2013;8(4):370–8.

Article  PubMed  Google Scholar 

Nakagawa Y, Suzuki K, Masaoka T. Evaluation of the risk factors for febrile neutropenia associated with hematological malignancy. J Infect Chemother. 2009;15(3):174–9.

Article  PubMed  Google Scholar 

Weycker D, Li X, Edelsberg J, Barron R, Kartashov A, Xu H, Lyman GH. Risk and consequences of Chemotherapy-Induced Febrile Neutropenia in patients with metastatic solid tumors. J Oncol Pract. 2015;11(1):47–54.

Article  PubMed  Google Scholar 

Yoo JG, Kim JH, Kim CJ, Lee HN, Song MJ, Park DC, Yoon JH, Kim SI, Hur SY, Lee SJ. Postoperative adjuvant Chemoradiotherapy Versus Chemotherapy alone for stage III endometrial Cancer: a Multicenter Retrospective Study. Cancer Control. 2022;29:10732748221115288.

Article  PubMed  PubMed Central  Google Scholar 

Yamaguchi M, Tobinai K, Oguchi M, Ishizuka N, Kobayashi Y, Isobe Y, Ishizawa K, Maseki N, Itoh K, Usui N, et al. Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211. J Clin Oncol. 2009;27(33):5594–600.

Article  CAS  PubMed  Google Scholar 

Klastersky J, de Naurois J, Rolston K, Rapoport B, Maschmeyer G, Aapro M, Herrstedt J. Management of febrile neutropaenia: ESMO Clinical Practice guidelines. Ann Oncol. 2016;27(suppl 5):v111–8.

Article  CAS  PubMed  Google Scholar 

Lyman GH, Lyman CH, Agboola O. Risk models for predicting chemotherapy-induced neutropenia. Oncologist. 2005;10(6):427–37.

Article  PubMed  Google Scholar 

Lyman GH, Abella E, Pettengell R. Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: a systematic review. Crit Rev Oncol Hematol. 2014;90(3):190–9.

Article  PubMed  Google Scholar 

Jenkins P, Freeman S. Pretreatment haematological laboratory values predict for excessive myelosuppression in patients receiving adjuvant FEC chemotherapy for breast cancer. Ann Oncol. 2009;20(1):34–40.

Article  CAS  PubMed  Google Scholar 

Bartlett NL, Rosenberg SA, Hoppe RT, Hancock SL, Horning SJ. Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin’s disease: a preliminary report. J Clin Oncol. 1995;13(5):1080–8.

Article  CAS  PubMed  Google Scholar 

Mell LK, Schomas DA, Salama JK, Devisetty K, Aydogan B, Miller RC, Jani AB, Kindler HL, Mundt AJ, Roeske JC, et al. Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2008;70(5):1431–7.

Article  PubMed  Google Scholar 

Terbuch A, Posch F, Partl R, Zurl B, Bauernhofer T, Pichler M, Szkandera J, Hutterer GC, Pummer K, Kapp KS, et al. Risk stratification for febrile neutropenia in patients with testicular germ cell tumors. Cancer Med. 2018;7(2):508–14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pettengell R, Bosly A, Szucs TD, Jackisch C, Leonard R, Paridaens R, Constenla M, Schwenkglenks M. Impact of Neutropenia in Chemotherapy-European Study G: multivariate analysis of febrile neutropenia occurrence in patients with non-hodgkin lymphoma: data from the INC-EU prospective observational European Neutropenia Study. Br J Haematol. 2009;144(5):677–85.

Article  PubMed  Google Scholar 

Savvides P, Terrin N, Erban J, Selker HP. Development and validation of a patient-specific predictive instrument for the need for dose reduction in chemotherapy for breast cancer: a potential decision aid for the use of myeloid growth factors. Support Care Cancer. 2003;11(5):313–20.

Article  PubMed  Google Scholar 

Xiao AT, Tong YX, Xu XS, Zhou Y, Zhang S. Preoperative Nutritional Status contributes to the development of Neutropenia Event in patients with gastric Cancer receiving CAPEOX adjuvant chemotherapy. Front Oncol. 2020;10:692.

Article  PubMed  PubMed Central  Google Scholar 

Lyman GH, Kuderer NM, Crawford J, Wolff DA, Culakova E, Poniewierski MS, Dale DC. Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapy. Cancer. 2011;117(9):1917–27.

Article  PubMed  Google Scholar 

Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42(1):121–30.

Article  CAS  PubMed  Google Scholar 

Milgrom SA, Kollmeier MA, Abu-Rustum NR, Tew WP, Sonoda Y, Barakat RR, Alektiar KM. Postoperative external beam radiation therapy and concurrent cisplatin followed by carboplatin/paclitaxel for stage III (FIGO 2009) endometrial cancer. Gynecol Oncol. 2013;130(3):436–40.

Article  CAS  PubMed  Google Scholar 

Wen Q, Shao Z, Yang Z. Concomitant paclitaxel plus carboplatin and radiotherapy for high-risk or advanced endometrial cancer. Int J Gynecol Cancer. 2013;23(4):685–9.

Article  PubMed  Google Scholar 

El-Hadaad HA, Wahba HA, Gamal AM, Dawod T. Adjuvant pelvic radiotherapy vs. sequential chemoradiotherapy for high-risk stage I-II endometrial carcinoma. Cancer Biol Med. 2012;9(3):168–71.

PubMed  PubMed Central  Google Scholar 

Ben Nasr S, Zriba S, Kacem K, Yahyaoui Y, El Benna H, Mansouri R, Ben Lakhal R, Meddeb B. [Impact of early lymphopenia on the risk of febrile neutropenia and hematological toxicity]. Tunis Med. 2015;93(5):283–6.

PubMed  Google Scholar 

Zhu Y, Guo D, Kong X, Liu S, Yu C. A risk-prediction Nomogram for Neutropenia or Febrile Neutropenia after Etoposide-based chemotherapy in Cancer patients: a retrospective cohort study. Pharmacology. 2022;107(1–2):69–80.

Article  CAS  PubMed  Google Scholar 

Corbeau I, Thezenas S, Maran-Gonzalez A, Colombo PE, Jacot W, Guiu S. Inflammatory blood markers as prognostic and predictive factors in early breast Cancer patients receiving Neoadjuvant Chemotherapy. Cancers (Basel) 2020, 12(9).

Shikata H, Yakushijin Y, Yamanouchi J, Azuma T, Yasukawa M. Analysis of chemotherapy-induced neutropenia and optimal timing for prophylactic use of G-CSF in B-cell non-hodgkin lymphoma patients treated with R-CHOP. Int J Clin Oncol. 2014;19(1):178–85.

Article  CAS  PubMed  Google Scholar 

Shimanuki M, Imanishi Y, Sato Y, Nakahara N, Totsuka D, Sato E, Iguchi S, Sato Y, Soma K, Araki Y, et al. Pretreatment monocyte counts and neutrophil counts predict the risk for febrile neutropenia in patients undergoing TPF chemotherapy for head and neck squamous cell carcinoma. Oncotarget. 2018;9(27):18970–84.

Article  PubMed  PubMed Central  Google Scholar 

Moreau M, Klastersky J, Schwarzbold A, Muanza F, Georgala A, Aoun M, Loizidou A, Barette M, Costantini S, Delmelle M, et al. A general chemotherapy myelotoxicity score to predict febrile neutropenia in hematological malignancies. Ann Oncol. 2009;20(3):513–9.

Article  CAS  PubMed  Google Scholar 

Oguz A, Karadeniz C, Ckitak EC, Cil V. Which one is a risk factor for chemotherapy-induced febrile neutropenia in childhood solid tumors: early lymphopenia or monocytopenia? Pediatr Hematol Oncol. 2006;23(2):143–51.

Article  PubMed